SQI Diagnostics Inc V.SQD.H

RE:IMPORTANT HIGHLIGHTS - MAY 12 INVESTOR DECK & RECENT AIF

[mercedesman]

To your point FF:

Critical Care Patients
More than 5 million patients are admitted annually to U.S. ICUs for intensive or invasive monitoring; support of airway, breathing, or circulation; stabilization of acute or life-threatening medical problems; comprehensive management of injury and/or illness; and maximization of comfort for dying patients. ICU patients are a heterogeneous population, but all share the need for frequent assessment and a greater need for technological support than patients admitted to non-ICU beds.

https://www.sccm.org/Communications/Critical-Care-Statistics


That's just ICU admissions.  What about out clinics?  Old Age homes?
Or, back to ICU's , all  of the retesting that should occur on some patients, over several days or weeks?



Lets use the understated 5 M to establish a target market for RALI- DX & fast

x $200 (to use your average)

= $ 1B USD

Let's say 15% penetration by 2024 = $ 150,000,000 annually (US market only)

But why shouldn't it be the standard everywhere - to identify the most at risk patients, or perhaps more importantly, of avoiding the legal mistake of sending the wrong patient home?

MM